A key Senate Republican and outspoken 340B critic recently argued that any comprehensive efforts to address healthcare affordability in Congress [...] …
Category: Providers
AbbVie and Novartis recently became the first drugmakers to file lawsuits challenging Oregon’s new law prohibiting 340B contract pharmacy restrictions. [...] …
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
340B covered entities and drugmakers offered competing criticisms Thursday of the Health Resources and Services Administration’s (HRSA) newly released 340B [...] …
The Health Resources and Services Administration (HRSA) today unveiled its highly anticipated 340B rebate guidance, proposing a pilot program that [...] …
Three patient groups are urging a federal appeals court to back drugmaker 340B rebate models they argue would bring transparency [...] …
Nearly 80 advocates marched toward Capitol Hill yesterday in a record turnout for the fourth annual “Defend 340B March” in [...] …
Although President Donald Trump’s nearly 900-page “big beautiful bill” never mentions the 340B program, experts warn that the new law’s [...] …
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
News Alert
Matsui, Welch Reintroduce 340B PATIENTS Act in Congress During 340B Coalition Summer Conference
The two congressional Democrats behind the 340B PATIENTS Act—a 2024 federal bill that would’ve codified providers’ ability to use 340B [...] …